Mechanism of Infectivity Acquisition in African Trypanosomes

非洲锥虫感染性获得机制

基本信息

  • 批准号:
    9010923
  • 负责人:
  • 金额:
    $ 41.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-03-15 至 2019-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Unraveling the biology of human pathogens is fundamental toward understanding mechanisms of pathogenesis and identifying genes essential for survival in the host. This application focuses on the protozoan parasite Trypanosoma brucei, which causes devastating diseases in humans and animals in sub-Saharan Africa. There are no vaccines, and therapeutic drugs have serious side effects and decreasing efficacy. T. brucei undergoes a complex life cycle between the mammalian host and the blood-feeding tsetse fly vector (Diptera: Glossinidae), which among others involves changes in cell morphology, metabolism, signaling pathways and gene expression. Consequently, these parasites have evolved adaptations to allow for their survival in both the gut and salivary glands of the tsetse fly, as well as in the bloodstream of their mammalian host. Upon feeding on an infected host, the tsetse fly takes up slender, intermediate and stumpy bloodstream forms. In the fly midgut stumpy forms differentiate into non-infectious procyclic forms. Reacquisition of infectivity is achieved through a complex developmental program that culminates in the tsetse salivary glands with the generation of infectious metacyclics. Although the intricate nature of trypanosome development in the fly has been recognized for more than a century, the molecular mechanisms are still mysterious, due in part to the experimental challenges posed by the tsetse fly. We found that overexpression of the T. brucei RNA-binding protein RBP6 in cultured non-infectious procyclic forms initiates differentiation into the developmental stages found in tsetse flies and culminates with the generation of infective metacyclics expressing the variant surface glycoprotein (VSG) coat. Our first goal will be to delineate the mechanism of action of RBP6. As RBP6 appears to be a "master regulator" triggering a cascade of events, it will be critical to identify the primary mRNA targets of RBP6. This will provide crucial information about gene products involved in the early stages of differentiation and for formulating a testable hypothesis about the cellular adaptations occurring in the transition from procyclic to epimastigotes forms. Our second goal will be to provide a transcriptomic and proteomic map of epimastigotes and metacyclics and to decode the biology of metacyclogenesis. Finally, the discovery of novel genes, besides VSG, required for metacyclic differentiation will be a major breakthrough toward deciphering how the process of acquisition of infectivity is brought about. Taken together our research plan provides unique opportunities to illuminate the differentiation program from procyclic to metacyclic and reveal the mode of action of an important RNA binding protein.
描述(申请人提供):解开人类病原体的生物学对于理解致病机制和识别在宿主中生存所必需的基因是基本的。这项应用的重点是原生动物寄生虫布鲁氏锥虫,这种寄生虫会在撒哈拉以南非洲的人和动物中造成毁灭性的疾病。没有疫苗,治疗药物副作用严重,疗效下降。布氏锥虫在哺乳动物宿主和食血采采蝇载体之间经历了一个复杂的生活史,其中包括细胞形态、代谢、信号通路和基因表达的变化。因此,这些寄生虫进化出适应能力,以便在采采蝇的肠道和唾液腺以及哺乳动物宿主的血液中生存。采采蝇在摄食受感染的宿主后,呈细长、中间和粗壮的血液形态。在苍蝇体内,中肠粗壮的形式分化为非感染性的原环状形式。感染性的重新获得是通过一个复杂的发育程序实现的,最终在采采期的唾液腺中产生具有感染性的后循环。尽管苍蝇体内锥虫发育的复杂本质已经被认识到一个多世纪,但分子机制仍然神秘,部分原因是采采蝇带来的实验挑战。我们发现,布鲁氏毛滴虫RNA结合蛋白RBP6在培养的非感染性原环状结构中的过表达启动了采采蝇的发育阶段,并最终产生了表达变异表面糖蛋白(VSG)外壳的感染性顺环体。我们的第一个目标将是描述RBP6的作用机制。由于RBP6似乎是触发一系列事件的“主调控因子”,因此确定RBP6的主要信使核糖核酸靶标至关重要。这将提供有关分化早期阶段所涉及的基因产物的关键信息,并为形成一个可检验的假说,即从原环状向上鞭毛体的转变过程中发生的细胞适应。我们的第二个目标将是提供上胚体和后周期的转录和蛋白质组学图谱,并破译后周期发生的生物学。最后,除了VSG外,新基因的发现将是破译感染力获得过程的重大突破,这些基因是元环分化所必需的。综上所述,我们的研究计划提供了独特的机会来阐明从原环到半环的分化程序,并揭示一种重要的RNA结合蛋白的作用方式。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHRISTIAN TSCHUDI其他文献

CHRISTIAN TSCHUDI的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHRISTIAN TSCHUDI', 18)}}的其他基金

Research Experience & Training Core
研究经历
  • 批准号:
    10361893
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
Control of VSG pre-mRNA processing in infectious Trypanosoma brucei
感染性布氏锥虫 VSG 前 mRNA 加工的控制
  • 批准号:
    10336793
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Control of VSG pre-mRNA processing in infectious Trypanosoma brucei
感染性布氏锥虫 VSG 前 mRNA 加工的控制
  • 批准号:
    10493377
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Control of VSG pre-mRNA processing in infectious Trypanosoma brucei
感染性布氏锥虫 VSG 前 mRNA 加工的控制
  • 批准号:
    10685494
  • 财政年份:
    2021
  • 资助金额:
    $ 41.63万
  • 项目类别:
Training in Parasitology and Vector Biology
寄生虫学和媒介生物学培训
  • 批准号:
    9390128
  • 财政年份:
    2016
  • 资助金额:
    $ 41.63万
  • 项目类别:
Mechanism of Infectivity Acquisition in African Trypanosomes
非洲锥虫感染性获得机制
  • 批准号:
    8660833
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Mechanism of Infectivity Acquisition in African Trypanosomes
非洲锥虫感染性获得机制
  • 批准号:
    8819099
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Mechanism of Infectivity Acquisition in African Trypanosomes
非洲锥虫感染性获得机制
  • 批准号:
    10356095
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Mechanism of Infectivity Acquisition in African Trypanosomes
非洲锥虫感染性获得机制
  • 批准号:
    10570251
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:
Mechanism of Infectivity Acquisition in African Trypanosomes
非洲锥虫感染性获得机制
  • 批准号:
    9230343
  • 财政年份:
    2014
  • 资助金额:
    $ 41.63万
  • 项目类别:

相似海外基金

Unraveling Adverse Effects of Checkpoint Inhibitors Using iPSC-derived Cardiac Organoids
使用 iPSC 衍生的心脏类器官揭示检查点抑制剂的副作用
  • 批准号:
    10591918
  • 财政年份:
    2023
  • 资助金额:
    $ 41.63万
  • 项目类别:
Optimization of mRNA-LNP vaccine for attenuating adverse effects and analysis of mechanism behind adverse effects
mRNA-LNP疫苗减轻不良反应的优化及不良反应机制分析
  • 批准号:
    23K15383
  • 财政年份:
    2023
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Elucidation of adverse effects of combined exposure to low-dose chemicals in the living environment on allergic diseases and attempts to reduce allergy
阐明生活环境中低剂量化学品联合暴露对过敏性疾病的不良影响并尝试减少过敏
  • 批准号:
    23H03556
  • 财政年份:
    2023
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Green tea-based nano-enhancer as an adjuvant for amplified efficacy and reduced adverse effects in anti-angiogenic drug treatments
基于绿茶的纳米增强剂作为抗血管生成药物治疗中增强疗效并减少不良反应的佐剂
  • 批准号:
    23K17212
  • 财政年份:
    2023
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Effects of Tobacco Heating System on the male reproductive function and towards to the reduce of the adverse effects.
烟草加热系统对男性生殖功能的影响以及减少不利影响。
  • 批准号:
    22H03519
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mitigating the Adverse Effects of Ultrafines in Pressure Filtration of Oil Sands Tailings
减轻油砂尾矿压力过滤中超细粉的不利影响
  • 批准号:
    563657-2021
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Alliance Grants
1/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
1/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10521849
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
4/4-Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
4/4-破译ECT结果和不良反应的机制(DECODE)
  • 批准号:
    10671022
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
2/4 Deciphering Mechanisms of ECT Outcomes and Adverse Effects (DECODE)
2/4 ECT 结果和不良反应的破译机制(DECODE)
  • 批准号:
    10670918
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
Adverse Effects of Using Laser Diagnostics in High-Speed Compressible Flows
在高速可压缩流中使用激光诊断的不利影响
  • 批准号:
    RGPIN-2018-04753
  • 财政年份:
    2022
  • 资助金额:
    $ 41.63万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了